ALB and hepatocellular carcinoma: In the analysis of 1245 patients who did not develop HCC within 6 months and who were observed for more than 6 months, 51 patients developed HCC, and age ≥73 years (HR: 1.782), male sex (HR: 2.835), HA ≥75 ng/mL (HR: 3.481), EOT-AFP ≥5.3 ng/mL (HR: 4.257), and Alb <3.9 g/dL (HR: 2.084) were associated with the development of HCC (Table 4).